CPhI Middle East & Africa 2025 – The Region’s Premier Pharmaceutical Manufacturing & Supply Chain Event
CPhI Middle East & Africa 2025 returns to the King Abdullah International Convention Center in Riyadh, uniting pharmaceutical manufacturers, ingredient suppliers, contract development and manufacturing organizations (CDMOs), packaging providers, machinery companies, and regulatory experts from across the Middle East, Africa, and global pharma hubs.
As one of the most important pharma events in the region, CPhI MEA connects global suppliers with fast-growing markets, driven by expanding healthcare investment, local manufacturing initiatives, and rising demand for pharmaceutical innovation across the MENA region.
Event Overview
Event Name: CPhI Middle East & Africa
Start Date: December 8, 2025
End Date: December 10, 2025
Venue: King Abdullah International Convention Center
Venue Address: HV8P+CFX, Eastern Ring Rd Ext, Riyadh 14332, Saudi Arabia
City: Riyadh
Country: Saudi Arabia
Event Website: https://www.cphi.com/mena/en/home.html/?utm_source=alsett.com
Venue Website: https://www.recexpo.com/?utm_source=alsett.com
ExpoMax360 Source: https://atlas.expomax360.com/event/cph-i-middle-east-africa/?utm_source=alsett.com
Introduction
CPhI Middle East & Africa brings the global pharmaceutical ecosystem together in one place, offering unmatched access to suppliers, manufacturers, and buyers across:
-
active pharmaceutical ingredients (APIs)
-
finished dosage formulations (FDF)
-
contract services (CDMO/CMO)
-
packaging & drug delivery
-
machinery & processing equipment
-
regulatory and compliance services
Attendees include:
-
pharmaceutical manufacturers
-
government healthcare agencies
-
procurement teams
-
biotech companies
-
distributors & importers
-
regulatory experts
-
R&D specialists
-
investors and supply-chain partners
For exhibitors, the event is the ideal entry and expansion point into emerging pharma markets in the Middle East and Africa.
What Exhibitors Can Expect
1. Active Pharmaceutical Ingredients (APIs) & Intermediates
This core segment includes:
-
small molecule APIs
-
generic API suppliers
-
intermediates & raw materials
-
specialty ingredients
-
complex molecule APIs
Local manufacturers and regional pharma companies attend to secure reliable suppliers.
2. Finished Dosage Formulations (FDF) & Contract Manufacturing
A strong category for companies offering:
-
tablets, capsules, injectables & oral liquids
-
biosimilars & biologics
-
branded & generic formulations
-
CDMO/CMO services
-
clinical and commercial production
Procurement teams from across MENA attend to build long-term relationships.
3. Pharmaceutical Machinery, Production Lines & Processing Equipment
Exhibitors showcase:
-
mixing & granulation equipment
-
tablet presses
-
coating machines
-
vial filling & sterile processing systems
-
packaging lines
-
automation & robotics
Manufacturers are actively expanding capacity in Saudi Arabia and the region.
4. Packaging, Drug Delivery & Serialization Solutions
A fast-growing segment includes:
-
primary packaging (vials, syringes, bottles)
-
secondary packaging
-
smart packaging & serialization systems
-
cold-chain solutions
-
inhalers, injectors & novel delivery systems
Compliance and patient safety drive strong demand.
5. Laboratory Equipment, Quality Control & Testing Solutions
Critical lab categories include:
-
analytical instruments
-
microbiology tools
-
stability chambers
-
QC/QA equipment
-
chromatography systems
-
lab automation
Regulatory compliance makes this a high-importance segment.
6. Regulatory, Compliance & Pharma Supply Chain Services
Exhibitors offer:
-
regulatory consulting
-
GMP certification support
-
logistics & distribution
-
supply-chain optimization
-
market access strategy
-
technology platforms for compliance
Governments and private-sector firms attend to improve regional pharma infrastructure.
Why CPhI Middle East & Africa 2025 Matters for Exhibitors
Access to One of the Fastest-Growing Pharma Markets
Saudi Arabia and the wider MEA region are investing heavily in:
-
local manufacturing
-
biotech innovation
-
modernization of healthcare systems
-
pharmaceuticals & biologics production
High-Purchasing Power Attendees
Regional buyers include:
-
government healthcare authorities
-
national pharma companies
-
international procurement offices
-
hospital and pharmacy chains
Strong Support for International Partnerships
CPhI MEA is the gateway for:
-
market entry
-
distributor agreements
-
licensing deals
-
manufacturing partnerships
-
supply-chain integration
Ideal Platform for Product Launches
Exhibitors frequently debut:
-
new ingredients
-
improved formulations
-
advanced machinery
-
innovative drug delivery systems
Strategic Location in Riyadh
Saudi Arabia is rapidly becoming a pharmaceutical hub for MENA, making the event’s location ideal for business growth.
Final Thoughts
CPhI Middle East & Africa 2025 is the essential event for global pharmaceutical manufacturers, suppliers, and technology providers aiming to expand in the Middle East and Africa.
For companies offering APIs, FDF, machinery, packaging, lab technology, or regulatory services, this expo offers unmatched access to high-value buyers and strategic partners.
Whether you’re entering the market or expanding your regional footprint, CPhI MEA is one of the most important industry opportunities of the year.
Industry: Pharmaceuticals, Manufacturing, APIs, Biotechnology
Tags: pharmaceutical expo Riyadh, CPhI Middle East Africa, pharma manufacturing event









